BRAF and targeted treatment for non-small cell lung cancer / 国际肿瘤学杂志
Journal of International Oncology
; (12): 625-627, 2016.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-497591
Responsible library:
WPRO
ABSTRACT
B-Raf kinase (BRAF) gene is a driver mutation,and is an effective target in the treatment of non-small cell lung cancer (NSCLC).Studies have shown that BRAF inhibitors are effective for treatment of NSCLC with BRAF mutant.It is important to understand the clinicopathologic features and the research progress of BRAF inhibitors for the individual treatment of NSCLC.
Full text:
Available
Database:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2016
Document type:
Article